It triggered an effective immune response against cancer cells to improve dendritic cell (DC) maturation and increase CD83-positive DC. SQDG18 stimulated the production of the pro-inflammatory cytokines IL-12 and INF-ɣ. This evidence concerns the gene CD83 and cancer.